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Abstract: 
The aim was to evaluate if 1-2 propanodiol plus calcium propionate (glycogenic precursor) 
supplementation during the transition period in high yielding dairy cows reduces metabolic 
and reproductive dysfunctions during early lactation. Cows (n= 202) were divided into two 
homogeneous groups regarding number of lactations and body condition score. 1) Treated 
group (GG; n= 112) received 60 g/cow/d for15 d of a glycogenic precursor during the 
transition period. 2) Control group (GC; n= 90) received no treatment. Postpartum levels of 
beta hydroxybutyrate (BHB) (GG= 0.9 ± 0.2 mmol/L vs GC =1.3 ± 0.2 mmol/L; P<0.05), 
and non-esterified fatty acids (NEFA) (GG= 0.6 ± 0.1 mEq/L vs GC = 0.8 ± 0.1 mEq/L; 
P<0.05) were higher in the GC-group. Similarly, GC-cows had a higher percentage of 
retained placenta (23 % vs 13 %; P≤0.06) subclinical ketosis (GG= 10 %, GC= 56 %; 
P<0.05), and mastitis (GG= 8 %, GC= 16 %; P<0.05). Metritis, dystocia, abortions, clinical 
ketosis, hypocalcemia and ruminal acidosis showed no differences between groups. 
Administration of a glycogenic precursor during the transition period demonstrated a positive 
effect upon BHB and NEFA blood levels during early lactation, with parallel decreases of 
subclinical ketosis and retained placenta; this could be an alternative to enhance the dairy 
herd reproductive efficiency. 
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Introduction 
 
 
During the first weeks of lactation, cows with a high milk production face a negative energy 
balance (NEB), because of the high energy usage promoted by an inadequate adaptation 
during the transition period and the low intake of dry matter during the beginning of the 
lactation(1,2). This situation promotes the mobilization of hepatic lipids, increasing the 
plasmatic levels of non-esterified fatty acids (NEFA) and beta hydroxybutyrate (BHB), 
which are considered as sensitive markers of NEB(3,4). Such physiologic and metabolic 
scenario may cause hepatic lesions leading to a high probability of suffering other disorders 
related to metabolic dysfunction such as ketosis, mastitis, metritis, hypocalcemia, abomasal 
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displacement and retained placenta(2). In fact, at the onset of lactation, BHB concentrations 
higher than 1.2 mmol/L are related with the presence of subclinical ketosis(5), and that levels 
of NEFA from 0.7 to 1.0 mEg/L are able to predict postpartum health problems(6). 
Considering all the processes that take place during the transition period and with the aim of 
maintaining normoglycemia, several metabolic alternatives have been used in order to 
maintain glycaemia to fulfill the requirements of the peripheral tissues(7). The last throughout 
the process of glycogenesis, which allows the production of glucose starting from the glucose 
precursors as propionate or propylene glycol(8-11). Based on the previous findings, the aim of 
this study was to evaluate the use of a glycogenic precursor during the transition period upon 
the blood levels of NEB (NEFA and BHB) and the incidence of metabolic and reproductive 
diseases at the beginning of lactation in high yielding dairy cows.  
 
 
Material and methods 
 
 
Study site, animals and management 
 
 
The research took place from August to September 2015, in the Comarca Lagunera (25° 44 
36 N, 103° 10 15 W; 1,111 m asl). This northern region of Mexico is characterized by an 
extremely hot-dry climate,  with temperatures ranging from  23 ºC  to 43 ºC in summer and 
2 ºC to 9 ºC in winter, annual mean rainfall of 240 mm and relative humidity of 29 to 83 %.  
The study was conducted in a commercial dairy herd with a stock of 1,600 Holstein cows, 
managed under an intensive production system in open pens. The cows were fed with a 
completely mixed diet (50 % forage and 50 % concentrate,  DM basis 1.62 Mcal/Kg NEL, 
18 % CP), formulated in order to fulfill the nutritional requirements of cows in lactation with 
a milk production > 33 kg milk/d(12). The cows were fed ad libitum with a daily fed leftover 
of 10 % of the feed offered in four times (06:0, 1000, 12:0 & 16:0 h). 
 
 
Health and reproductive management 
 
 
All cows received four intramammary infusions of 375 mg of cephalexin (Rilexine®, Virbac, 
Mexico), during the dry period. Also, cows received a prolonged released cake consisting in 
micro minerals and vitamins A, D and E (Megabric®, Neolite, Laboratory, France). Routine 
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control of mastitis included disinfection of nipples before and after milking, the California 
mastitis test and a regular somatic cell count. 
 
Cows included in this study were subjected to a reproductive management of fresh cows from 
d 0 to 10; in order to achieve an adequate uterine involution, a 25 mg PGF2α injection was 
administered on d 35 and 47 postpartum. Besides, every cow was vaccinated according to 
the vaccine preventive program of the herd, mainly focused against diseases like bovine viral 
diarrhea, infectious bovine rhinotracheitis, bovine respiratory syncytial virus, parainfluenza 
type 3 and leptospirosis (5 varieties). 
 
 
Experimental design and response variables 
 
 
Cows (n= 202) with no reproductive issues were selected and divided into two homogenous 
groups regarding the number of previous lactations (3.2 ± 1.17) and body condition score 
(3.3 ± 0.5; 1-5 scale). While the average milk production at 305 d was 12,200 ± 147 kg the 
average number of inseminations was 3.7 ± 2.4 (1-10 inseminations range). A first group of 
cows (n= 112; GG; 41.1 ± 0.7 L per day) received a daily administration of 60 g/cow of a 
glycogenic precursor (1-2 propanediol and calcium propionate, Lipofeed®, Mexico) during 
the first 15 d of the transition period, which was added to the diet, while the second group 
(n= 90; GC; 40.1 ± 0.7 L per day) received no treatment. 
 
 
Fatty acids and beta hydroxybutyric acid 
 
 
Concentrations (mean ± SE) of non-esterified fatty acids (NEFA) in serum was determined 
by taking a coccygeal blood sample with vacuum tubes (BD Vacutainer®) at 7, 14 and 21 d 
postpartum; the obtained samples were identified and refrigerated until they arrived at the 
laboratory where they were centrifuged (450 g𝑥 20 min), afterwards, they were frozen and 
stored at -20 ºC until analyzed. In vitro quantitative determination of serum NEFA was 
performed with an automatic analyzer (Randox RX Monza®, USA), while the determination 
of concentrations (mean ± SE) of beta-hydrybutyric acid (BHB) at 7, 14 and 21 d postpartum 
was done with a portable BHB-meter (Precision Xtra system tests®), which consists of the 
use of reagent strips to quantify the ketone bodies in blood(3,13). 
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Metabolic diseases 
 
 
The percentage of cows with clinical ketosis was calculated, it was diagnosed based on a low 
milk yield and decreased appetite and the percentage of subclinical ketosis was determined 
with reagent strips during the first 21 d in milk. In addition, their relationship with other 
clinical diseases during the first 35 d postpartum were also evaluated(14). The occurrence of 
clinical mastitis was detected at milking by determining heat and inflammation by touching 
the udder and by evaluating consistency changes of the milk (watery-bloody, secretions and 
blood clots); this was daily performed during the first 3 wk postpartum(15). 
 
 
Reproductive diseases 
 
 
Percentage of cows with retained placenta (RP) was quantified in both groups, and was 
defined as the failure to expel fetal membranes within the first 24 h after parturition(16) and 
diagnosed by observing the presence of fetal membranes protruding from the vulva for more 
than 24 h after parturition. Metritis was defined as the inflammation that involved all the 
uterine wall(17). This was confirmed by evaluating, by rectal palpation, the size of the uterus 
in relation to the moment of parturition, the uterine wall thickness and the presence of liquid 
in one or both uterine horns. Abortion was defined as fetal death and expulsion between 50 
and 260 d of pregnancy. 
 
 
Statistical analyses 
 
 
Blood concentrations of BHB and NEFA were analyzed with the GLM procedure and mean 
comparison was performed by a Student-T. Percentage of cows showing reproductive 
(retained placenta, metritis, abortion and dystocia) and metabolic (clinical and subclinical 
ketosis, hypocalcemia, mastitis and ruminal acidosis) diseases, was calculated and compared 
by a X2 test. All analyses were performed with the SAS program, considering a significance 
level of P<0.05 and of P>0.05 and P≤0.10 for statistical tendency. 
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Results 
 
 
BHB and NEFA concentrations 
 
 
The results for concentrations of BHB and NEFA for both groups at 7, 14 and 21 d 
postpartum are shown in Figure 1. Levels of BHB during the first 3 wk of lactation were 
higher in the GC-cows (1.3 ± 0.2 vs 0.9 ± 0.2 mmol/L; P<0.05). No differences were found 
neither in time nor treatment at d 7 postpartum. Nonetheless, a difference was found between 
time and treatment at 14 and 21 d postpartum (P<0.05). Moreover, NEFA levels were higher 
for GC cows (0.8 ± 0.1 vs 0.6 ± 0.1 mEq/L; P<0.05).  A treatment 𝑥 time interaction effect 
occurred at 7, 14 and 21 d postpartum (P<0.05). 
 
Figure 1: Postpartum blood levels of non-esterified fatty acids (NEFA) and BHB (mean ± 
SE) in high yielding dairy cows treated (GG) or non-treated (GC) with a glucose precursor 
for 15 d during the transition period 
 
*Significant difference (P<0.05). 
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Reproductive and metabolic dysfunction incidence 
 
 
Table 1 concentrates the percentage for reproductive and metabolic diseases in both 
experimental groups. The percentage of retained placenta for GG cows was 13 % (15/112) 
vs 23 % (21/90) for the GC-cows, (P≥0.06). No differences between experimental groups 
(P>0.05) occurred for percentages of metritis, dystocia or abortion. In relation to metabolic 
diseases, a higher percentage (P<0.05) of subclinical ketosis was observed in the GC-cows 
(56 %; 50/90 vs 10 %; 12/112) as well as for mastitis (18 %; 16/90 vs 8 %; 9/112, 
respectively). No differences were observed for the remaining metabolic diseases between 
experimental groups (P>0.05). 
 
Table 1: Percentage of postpartum reproductive and metabolic diseases of dairy cows 
treated (GG) or no treated (GC) with a glucose precursor for 15 d during the transition 
period (%) 
Variables 
Groups 
 P value 
GG (n= 112) GC (n =90)   
Reproductive diseases:     
Retained placenta  13 (15/112) 23 (21/90)  0.067 
Metritis  5 (6/112) 11 (10/90)  0.132 
Dystocia  7 (8/112) 11 (10/90)  0.325 
Abortion  1 (1/112) 2 (2/90)  0.438 
     
Metabolic diseases:     
Clinical ketosis  1 (1/112) 3 (3/90)  0.216 
Subclinical ketosis  10 (12/112 56 (50/90)  0.000 
Hypocalcemia  1 (1/112) 1 (1/90)  0.864 
Mastitis  8 (9/112) 18 (16/90)  0.037 
Ruminal acidosis  6 (10/112) 10 (9/90)  0.467 
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Discussion 
 
 
The results demonstrate that cows treated with a glycogenic precursor during the transition 
period depicted a lower NEB regarding the non-treated cows. In fact, females facing NEB 
have higher BHB levels(18); high yielding dairy cows during the beginning of lactation 
increase their glucose requirements for lactose production and, with the lack of this, the 
animal mobilizes the glycogenic substrates that originate ketone bodies(19). The last could 
probably be due because such glycogenic precursor is an important substrate for 
gluconeogenesis, which may have stimulated the hepatic glycogen dynamic that is necessary 
to satisfy the requirements of hepatic glucose during the transition period(19). In fact, some 
studies have demonstrated that the use of propionate(10,11), or propylene glycol(8,9), stimulate 
glucose synthesis in dairy cows at the beginning of lactation(20). The above probably helped 
to reduce the blood BHB levels in the GG-cows; it has been stated that glycogenic precursors 
decrease ketonic bodies concentration(20). On the other hand, the administration of a 
glycogenic precursor decreased the blood NEFA concentrations in the GG-cows (0.6 ± 0.1 
mEq/L) compared to GC-cows (0.8 ± 0.01 mEq/L), suggesting that the GG-cows were 
probably on a less intense NEB regarding the control-cows(6). Certainly, at the beginning of 
lactation cows face a NEB, due to the high milk yield which parallels a decrease in feed 
consumption, causing an increased lipid mobilization from body fat to the liver in order to 
make available the required glucose levels essential to compensate the observed energy 
deficit during the NEB(1,6,21). 
 
Therefore, those cows treated with the glycogenic precursor during the transition period 
decreased the incidence of females facing metabolic disturbances. In fact, the GG-cows had 
less subclinical ketosis than the control cows (10 % vs 56 %). McArt et al(18) indicate that the 
mean level of BHB in blood to assume the presence of a subclinical ketosis is > 1.2 mmol/L, 
which was near the average for the non-treated group (1.3 mmol/L). Indeed, more than 50 % 
of the cows in the GC showed subclinical ketosis, which is a risk factor for the health of the 
animals, and increases the incidence of reproductive diseases during the cool period. In 
addition, subclinical ketosis also increases the return-to-estrus interval, as well as, rises the 
rate of waste of the herd while it decreases milk production, causing economic losses(3,4,14). 
This was probably due because of the administration of the glycogenic precursor which 
reduced, in turn, the circulating BHB concentrations (0.9 mmol/L in the GG-cows), 
suggesting failures in the adaptation ability during the transition period(22). Certainly, a high 
milk yielding cow has a high glucose demand for lactose production.  Yet, since there is a 
lack of blood glucose, cows try to compensate such metabolic challenge by mobilizing lipids 
from liver. Such physiological and metabolic scenario probably provoked that the control 
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cows generated an increased serum BHB level which, in turn, provoked a high percentage of 
subclinical ketosis(6,19,20). The last, may also promoted an increased risk of diseases like fat 
liver and ketosis(6,10,20). 
 
On the other hand, the GG-cows had 50 % less clinical mastitis than the control-cows. The 
last probably was due to the fact that control-cows had blood BHB concentrations ≥ 0.6 
mmol/L from the pre-partum to the beginning of lactation, which has been reported as a factor 
that increases the probability of cows presenting pre-partum diseases and a consequent 
decrease in milk production(6,23). This scenario probably occurred because ketosis has been 
associated as a factor that increases the risk of clinical mastitis(14,24). Moreover, NEFA 
increases (≥ 0.8 mEq/L) is another risk factor associated to other diseases like metritis, 
mastitis and clinical ketosis(4,6). Certainly, any unbalance of both energy status and health 
status, decreases the immune compensatory response of cows and make them susceptible to 
poorly counteract any health compromising insult(25). Studies have demonstrated that high 
concentrations of NEFA are related with metabolic and inflammatory diseases that induce 
inflammation and affect the immune system(26,27). On the other hand, the reduced percentage 
of cows with retained placenta, in comparison with the control cows, could be explained 
because of the treated cows had a better energetic metabolism which improved the 
functionality of their immune system and, in consequence, promoted less incidence of 
inflammation processes(28). The low NEFA concentrations of the GG-cows, it is known to 
increase the blood lipid content while a higher serum NEFA concentration, and it is 
associated with a higher incidence of peri-parturient diseases (i.e. retained placenta, abomasal 
displacement) as well as the predisposition to inflammatory diseases (i.e mastitis, 
metritis)(29,30) the last may have increased the percentage of retained placenta incidence(22,31). 
Furthermore, a higher concentration of blood BHB, generates a higher risk of cows 
presenting reproductive diseases(3,4). 
 
 
Conclusions and implications 
 
 
Cows treated with a glycogenic precursor during the transition period reduced the impact of 
the negative energy balance and, in consequence, diminished some health problems such as 
retained placentas, subclinical ketosis and mastitis at the beginning of lactation.  The results 
indicate also that such supplementation strategy could be an interesting alternative to 
positively influence the energetic balance during the transition period of dairy cows while 
improving their health status. All of these metabolic and health responses should contribute 
to improve the reproductive efficiency of high yielding dairy cows.  
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